• No results found

Decompensated cirrhosis

Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study

Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study

... and decompensated cirrhosis and who underwent liver transplantation can experience reduced GFR or even acute renal failure dur- ing pre- and post-transplantation therapy with a sofosbuvir-based regimens ...

8

Quality of Life of Patients with Decompensated Cirrhosis Who Undergoing Serial Large Volume Paracentesis

Quality of Life of Patients with Decompensated Cirrhosis Who Undergoing Serial Large Volume Paracentesis

... the cirrhosis stage is fully settled and the condition is usually ...of cirrhosis, the necroinflammatory process in the liver may have subsided and is thus not included in the definition [1, ...of ...

5

Prognostic value of liver stiffness in HIV/HCV Coinfected patients with decompensated cirrhosis

Prognostic value of liver stiffness in HIV/HCV Coinfected patients with decompensated cirrhosis

... and decompensated cirrhosis. In compensated cirrhosis, portal pressure is the main determinant of prognosis, depends mainly on intrahepatic factors [20], and can be accurately estimated using ...

6

Plasma diamine oxidase level predicts 6 month readmission for patients with hepatitis B virus related decompensated cirrhosis

Plasma diamine oxidase level predicts 6 month readmission for patients with hepatitis B virus related decompensated cirrhosis

... HE. Therefore, in patients with decompensated cirrhosis, plasma DAO levels reflect the severity of cirrhosis in pa- tients. TLRs (Toll-like receptors) are natural immune re- ceptors in the liver, ...

14

Hepatic Venous Pressure Gradient Predicts Long Term Mortality in Patients with Decompensated Cirrhosis

Hepatic Venous Pressure Gradient Predicts Long Term Mortality in Patients with Decompensated Cirrhosis

... with decompensated liver ...with decompensated cirrhosis at high risk for death: improving the prediction by hepatic venous pressure gra- dient? Hepatogastroenterology ...

8

The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain

The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain

... in decompensated cirrhosis due to its perceived high cost ...these cirrhosis complica- tions and their downstream healthcare costs, such as repeat hospitalizations, also have to be taken into ac- ...

10

Validity of an automated algorithm using diagnosis and procedure codes to identify decompensated cirrhosis using electronic health records

Validity of an automated algorithm using diagnosis and procedure codes to identify decompensated cirrhosis using electronic health records

... hepatitis-induced cirrhosis can progress to decompensated ...with cirrhosis, yet there remains uncertainty regarding precisely how to define this important ...to decompensated cirrhosis ...

8

Patient oriented education and medication management intervention for people with decompensated cirrhosis: study protocol for a randomized controlled trial

Patient oriented education and medication management intervention for people with decompensated cirrhosis: study protocol for a randomized controlled trial

... of cirrhosis, medications, self-monitoring, and important dietary and lifestyle modifications has been described in ambulatory Australian patients with cirrhosis ...with cirrhosis attending general ...

13

Cohort study of the impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis

Cohort study of the impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis

... and decompensated cirrhosis or at risk of irreversible disease were treated in an Expanded Access Programme (EAP) in ...and decompensated cirrhosis who were registered on a database 6 months ...

37

Outcomes after successful direct acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis

Outcomes after successful direct acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis

... with decompensated cirrhosis treated on the 106 English Expanded Access Programme (EAP) with 12 weeks of 107 sofosbuvir and a NS5A inhibitor with or without ribavirin ...with decompensated ...

9

Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis B in patients with decompensated cirrhosis from a third-party US payer perspective

Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis B in patients with decompensated cirrhosis from a third-party US payer perspective

... pensated cirrhosis state, and moving from the HCC-free decompensated cirrhosis state to the death state were based on parametric regression analysis of as-treated, cumulative HCC-free survival, and ...

9

Role of Portal Hypertension in Prediction of Bacterial Infection in Decompensated Cirrhosis

Role of Portal Hypertension in Prediction of Bacterial Infection in Decompensated Cirrhosis

... History of hematemesis was encountered in 20 patients (20.2%). Ascites was found in 90 patients (91%); 49 of them were mild degree, 24 moderate and 17 patients presented by marked ascites. Hepatic encephalopathy as a ...

8

Macrocytic anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective cross-sectional study

Macrocytic anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective cross-sectional study

... 3. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic ...

7

Systemic inflammatory response syndrome and model for end-stage liver disease score accurately predict the in-hospital mortality of black African patients with decompensated cirrhosis at initial hospitalization: a retrospective cohort study

Systemic inflammatory response syndrome and model for end-stage liver disease score accurately predict the in-hospital mortality of black African patients with decompensated cirrhosis at initial hospitalization: a retrospective cohort study

... Among 317 patients hospitalized, during the study period, 159 patients (median age: 49 years old, 70.4% males) having cirrhosis were included in this study. Patients excluded were those having hepatocellular ...

10

Management options in decompensated cirrhosis

Management options in decompensated cirrhosis

... While cirrhosis often progresses undetected until a patient develops signs of dec­ ompensation, there are physical examination findings that suggest development of portal ...in cirrhosis is a result of both ...

8

THE EFFECT OF CHANGING SERUM OSMOLALITY ON THE RELEASE OF ANTIDIURETIC HORMONE IN CERTAIN PATIENTS WITH DECOMPENSATED CIRRHOSIS OF THE LIVER AND LOW SERUM OSMOLALITY

THE EFFECT OF CHANGING SERUM OSMOLALITY ON THE RELEASE OF ANTIDIURETIC HORMONE IN CERTAIN PATIENTS WITH DECOMPENSATED CIRRHOSIS OF THE LIVER AND LOW SERUM OSMOLALITY

... It is concluded that these subjects with low serum sodium and total solute concentration were sensitive to further changes in tonicity, and that the release of antidiuretic hormone was r[r] ...

7

Entecavir for treatment of chronic hepatitis B: A clinical update for the treatment of patients with decompensated cirrhosis

Entecavir for treatment of chronic hepatitis B: A clinical update for the treatment of patients with decompensated cirrhosis

... Entecavir is a once-daily orally available guanosine NA with potent and selective antiviral activity against HBV [21]. Entecavir was first approved in the United States in 2005 for treatment of chronic HBV infection in ...

9

Absolute quantification of microparticles by flow cytometry in ascites of patients with decompensated cirrhosis: a cohort study

Absolute quantification of microparticles by flow cytometry in ascites of patients with decompensated cirrhosis: a cohort study

... Our survival analysis emphasized the clinical relevance of absolute ascites MP levels in cirrhosis. Patients with a cut-off level below 488.4 MP/μL died more frequently than patients with high levels (30-day ...

10

Large-volume paracentesis effects plasma disappearance rate of indo-cyanine green in critically ill patients with decompensated liver cirrhosis and intraabdominal hypertension

Large-volume paracentesis effects plasma disappearance rate of indo-cyanine green in critically ill patients with decompensated liver cirrhosis and intraabdominal hypertension

... Considered as secondary endpoints of this study, we analyzed the impact of LVP on respiratory and circula- tory function in case of decompensated cirrhosis. We registered an overall beneficial effect on ...

10

Review Article Treatment of Hepatitis B in Decompensated Liver Cirrhosis

Review Article Treatment of Hepatitis B in Decompensated Liver Cirrhosis

... in decompensated HBV cirrhosis with resultant stabilization or improvement in liver ...with decompensated HBV cirrhosis ...with decompensated cirrhosis are in ...with ...

12

Show all 705 documents...

Related subjects